Australian-New Zealand Clinical Trial: A study to investigate safety, and pharmacokinetics, of single (SAD) and multiple (MAD) ascending doses of GE8820 in healthy adults

Australia, Oct. 14 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘A study to investigate safety, and pharmacokinetics, of single (SAD) and multiple (MAD) ascending doses of GE8820 in healthy adults’. The following are the other relevant details related to the trial:

Trial ID: 390268

Submit Date: 9/23/25 14:13

Study Type: Interventional

Intervention: This is a randomized, double-blind (participant and clinical assessor-blinded; sponsor open), placebo-controlled study in healthy adults to evaluate the safety and pharmacokinetics of GE8820 after single and multiple doses administered by intravenous infusion or subcutaneous injection. An additional 3 cohorts for Part A and 5...